Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure

Stopped early

Conditions studied: Patent Ductus Arteriosus

In brief

Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.

Key facts

Study ID

NCT03026192

Run by

Albany Medical College

People needed

4

Starts

2016-12-01

Expected to finish

2018-06-30

Last updated by the study team

2019-01-23

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• preterm infants less than 32 weeks gestation

You may not qualify if…

• infection, congenital heart disease, syndromic anomalies, and perinatal asphyxia.

Where it is running

• Albany Medical Center Neonatal Intesive Care Unit — Albany, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.